HRT FINANCIAL LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 165 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$11
-100.0%
18,256
-62.0%
0.00%
Q4 2021$52,000
-95.5%
48,063
-92.5%
0.00%
-100.0%
Q3 2021$1,163,000
+82.3%
639,207
+164.2%
0.01%
+16.7%
Q2 2021$638,000
+303.8%
241,922
+554.2%
0.01%
-14.3%
Q3 2019$158,000
-16.8%
36,981
+132.8%
0.01%
-92.1%
Q2 2015$190,00015,8850.09%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders